Derivision (01846) plans to invest approximately HK$119 million to acquire ophthalmic assets in Switzerland and the UK, increasing its presence in the European refractive surgery market.

Smart Finance News App, Devekia (01846) announced that on September 2, 2025 (after trading hours), the company's wholly-owned subsidiary EuroEyes Swiss (as the buyer), the company (as the guarantor), and Betterview Swiss (as the seller) entered into a Swiss agreement. EuroEyes Swiss agreed to purchase Swiss assets from Betterview Swiss for a total price of 12.01 million Swiss francs (equivalent to approximately 117 million Hong Kong dollars).